Search Results
Jul 01, 2026, 09:15 ET Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA
transplantation in highly sensitized patients, and HNSA-5487, a next-generation IgG-cleaving molecule that will be developed for Guillain-Barré Syndrome (GBS). Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the US The Company is listed on Nasdaq Stockholm under the ticker HNSA.
More news about: Hansa Biopharma AB
Jun 30, 2026, 08:00 ET Genpact Introduces Agentic Deductions Solution to Recover Lost Revenue for Consumer Goods Companies
entry."Visibility and control are essential given the nature of deductions in a complex business environment like ours," said Dylan Jetha, Global Trade to Cash (GBS), Kraft Heinz. "Genpact has been a long-time partner with a strong focus on continuously improving accounts receivable outcomes. It's encouraging
More news about: Genpact
Jun 23, 2026, 13:16 ET EaseUS Unveils New Update to Its Partition Manager Software - EaseUS Partition Master 20.5 with New Clean Hub to Streamline Space Management
scans, about 50% of users had more than 5 GB of junk files, and 20% had more than 10 GB. With this partition manager, users can clean up multiple GBs(3-10GB) in minutes.Remove Preinstalled Windows Apps and Bloatware Safely with 100% Uninstall SupportThe application management area has also
More news about: EaseUS Software
May 29, 2026, 02:21 ET Aokah réduit de 10 semaines à moins d'une semaine la sélection du site d'implantation d'un GCC pour les entreprises du Fortune 500 et obtient la désignation HFS Hot Tech pour son modèle Services-as-Software reposant sur l'IA
outre qu'Aokah est également utilisée en marque blanche par des sociétés de conseil et de recherche, ce qui signifie que les responsables des services GBS dans les entreprises utilisent peut-être déjà Aokah comme moteur d'intelligence sous-jacent sans s'en rendre compte. HFS conseille aux acheteurs de demander
More news about: Aokah Inc
May 28, 2026, 23:30 ET Aokah Compresses Fortune 500 GCC Site Selection From 10 Weeks to Less Than One Week, Earns HFS Hot Tech Designation for AI-Native Services-as-Software Model
specialist GCC advisory firms.The report further notes that Aokah is also being white-labeled by consulting and research firms, meaning enterprise GBS leaders may already be using Aokah as the underlying intelligence engine without realizing it. HFS advises buyers to ask their consulting partners which
More news about: Aokah Inc
May 28, 2026, 17:06 ET Aokah verkürzt die Standortauswahl für ein Fortune-500-Unternehmen im Golf-Kooperationsrat von 10 Wochen auf weniger als eine Woche und erhält die Auszeichnung „HFS Hot Tech" für sein KI-basiertes „Services-as-Software"-Modell
besetzt.Der Bericht stellt ferner fest, dass Aokah auch von Beratungs- und Forschungsunternehmen als White-Label-Lösung genutzt wird, was bedeutet, dass GBS-Führungskräfte in Unternehmen Aokah möglicherweise bereits als zugrunde liegende Intelligence-Engine einsetzen, ohne es zu wissen. HFS rät Käufern, ihre
More news about: Aokah Inc
May 28, 2026, 11:02 ET Aokah reduce el proceso de selección de ubicaciones para empresas Fortune 500 en el CCG
también señala que Aokah está siendo comercializada bajo marca blanca por firmas de consultoría e investigación, lo que significa que los líderes de GBS podrían estar utilizando Aokah como motor de inteligencia subyacente sin darse cuenta. HFS recomienda a los compradores que pregunten a sus socios de
More news about: Aokah Inc
May 28, 2026, 09:00 ET Aokah Compresses Fortune 500 GCC Site Selection From 10 Weeks to Less Than One Week, Earns HFS Hot Tech Designation for AI-Native Services-as-Software Model
specialist GCC advisory firms.The report further notes that Aokah is also being white-labeled by consulting and research firms, meaning enterprise GBS leaders may already be using Aokah as the underlying intelligence engine without realizing it. HFS advises buyers to ask their consulting partners which
More news about: Aokah Inc
May 27, 2026, 02:28 ET Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation
transplantation in highly sensitized patients, and HNSA-5487, a next-generation IgG-cleaving molecule that will be developed for Guillain-Barré Syndrome (GBS). Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the U.S. The company is listed on Nasdaq Stockholm under the ticker HNSA.
More news about: Hansa Biopharma AB
May 27, 2026, 02:25 ET Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation
transplantation in highly sensitized patients, and HNSA-5487, a next-generation IgG-cleaving molecule that will be developed for Guillain-Barré Syndrome (GBS). Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the U.S. The company is listed on Nasdaq Stockholm under the ticker HNSA.
More news about: Hansa Biopharma AB
May 25, 2026, 22:53 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
transplantation in highly sensitized patients, and HNSA-5487, a next-generation IgG-cleaving molecule that will be developed for Guillain-Barré Syndrome (GBS). Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the U.S. The company is listed on Nasdaq Stockholm under the ticker HNSA.
More news about: Hansa Biopharma AB
May 25, 2026, 22:52 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
transplantation in highly sensitized patients, and HNSA-5487, a next-generation IgG-cleaving molecule that will be developed for Guillain-Barré Syndrome (GBS). Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the U.S. The company is listed on Nasdaq Stockholm under the ticker HNSA.
More news about: Hansa Biopharma AB
May 22, 2026, 17:37 ET Costa Rica hat seine Bemühungen zur Investitionsförderung in Europa in den Bereichen Agrartechnologie, globale Dienstleistungen und Tourismusinfrastruktur verstärkt
& Outsourcing Week Europe 2026" teilnahmen. Die Veranstaltung gilt als eines der wichtigsten internationalen Foren für Global Business Services (GBS), Shared Services, Automatisierung, künstliche Intelligenz und digitale Transformation.Im Rahmen von Treffen und Networking-Veranstaltungen positionierte
More news about: Promotora de Comercio Exterior de Costa Rica (PROCOMER)
May 22, 2026, 13:49 ET PROCOMER busca de nuevas inversiones en agroindustria, servicios e infraestructura turística en Europa
internacionales que participan en el Shared Services & Outsourcing Week (SSOW) Europa. Este evento reunió a líderes globales de Global Business Services (GBS), Shared Services, automatización, inteligencia artificial y transformación digital, convirtiéndose en un espacio clave para identificar tendencias,
More news about: Promotora de Comercio Exterior de Costa Rica (PROCOMER)
May 22, 2026, 12:06 ET Costa Rica Strengthened Investment Promotion Efforts in Europe Across Agritech, Global Services and Tourism Infrastructure
Shared Services & Outsourcing Week Europe 2026. The event is considered one of the most important international forums for Global Business Services (GBS), shared services, automation, artificial intelligence and digital transformation.Through meetings and networking engagements, PROCOMER positioned
More news about: Promotora de Comercio Exterior de Costa Rica (PROCOMER)
May 19, 2026, 02:23 ET Hansa Biopharma enters into €115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA
transplantation in highly sensitized patients, and HNSA-5487, a next-generation IgG-cleaving molecule that will be developed for Guillain-Barré Syndrome (GBS). Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the U.S. The Company is listed on NASDAQ Stockholm under the ticker HNSA.
More news about: Hansa Biopharma AB
May 19, 2026, 02:20 ET Hansa Biopharma enters into €115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA
transplantation in highly sensitized patients, and HNSA-5487, a next-generation IgG-cleaving molecule that will be developed for Guillain-Barré Syndrome (GBS). Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the U.S. The Company is listed on NASDAQ Stockholm under the ticker HNSA.
More news about: Hansa Biopharma AB
May 11, 2026, 09:49 ET Inflow lança linha Kids e amplia portfólio com produtos infantis modulares e interativos
https://drive.google.com/drive/folders/1wERTYP5Gbs4J3jDr5VDAkmhl1U_CGcv8
More news about: Inflow
Apr 28, 2026, 10:30 ET Genpact Named a Leader in ISG Provider Lens™ 2026 ServiceNow Ecosystem Partners
Genpact's ability to bring together agentic AI, process intelligence, and deep domain expertise to drive transformation across IT, global business services (GBS), and industry workflows.HighlightsRecognition: ISG named Genpact a Leader in ISG Provider Lens™ 2026
More news about: Genpact
Apr 28, 2026, 02:50 ET HKMA 傑出市場策劃精英會隆重啟動
傑出市場策劃精英會正式啟動承傳這一深厚基礎，「HKMA 傑出市場策劃精英會」匯聚歷屆得獎者及市場推廣精英和領袖，致力推動行業發展、跨界交流、培育人才，並作為策略智庫，為特區政府、中小企業及初創提供洞見，助力香港經濟發展及區域競爭力。應家柏教授致歡迎辭：開拓跨界協作新機遇香港管理專業協會主席應家柏教授 GBS JP 在歡迎辭中表示：「今天標誌著一個重要的里程碑，HKMA 傑出市場策劃精英會正式成立，匯聚了市場營銷與商界的傑出領袖。精英會旨在成為促進協作、激發創新、為商界提供思想領導力的平台，同時培育未來的市場營銷人才。有見及此，今天的領袖論壇既合時宜，亦別具意義。透過匯聚市場營銷、商界及體育界的領袖，探討跨界別合作如何能夠發掘新機遇，並為香港的持續發展貢獻力量。」林國誠先生開幕演辭：攜手塑造行業未來HKMA
More news about: 香港管理專業協會
Apr 24, 2026, 09:07 ET Aokah lance Explorer et Builder : la première plateforme alimentée par l'IA qui permet aux entreprises de passer de la stratégie à l'exécution GCC
globaux avec prévoyance, rapidité et résilience. Fondée par une équipe de renommée mondiale ayant plus de 25 ans d'expérience dans le domaine des GCC, GBS et des services commerciaux mondiaux, Aokah combine l'IA agentique avec l'expertise des praticiens codifiée à partir de plus de 300 programmes GCC d'entreprise
More news about: Aokah Inc
Apr 24, 2026, 03:01 ET Aokah lanciert Explorer und Builder: Die erste KI-gestützte Plattform, die Unternehmen bei der Umsetzung ihrer GCC-Strategie unterstützt
Schnelligkeit und Widerstandsfähigkeit zu koordinieren. Gegründet von einem weltweit anerkannten Team mit über 25 Jahren Führungserfahrung in den Bereichen GCC, GBS und globale Unternehmensdienstleistungen, kombiniert Aokah agentenbasierte KI mit praktischem Fachwissen, das aus über 300 GCC-Programmen in Unternehmen
More news about: Aokah Inc
Apr 23, 2026, 09:00 ET Aokah Launches Explorer and Builder: The First AI-Powered Platform to Take Enterprises from GCC Strategy to Execution
built to orchestrate Global Capability Centers with foresight, speed, and resilience. Founded by a globally recognized team with over 25 years of GCC, GBS, and global business services leadership experience, Aokah combines agentic AI with practitioner expertise codified from 300+ enterprise GCC programs
More news about: Aokah Inc
Apr 23, 2026, 08:01 ET Aokah lanza Explorer y Builder
Globales con visión de futuro, rapidez y resiliencia. Fundada por un equipo reconocido mundialmente con más de 25 años de experiencia en liderazgo de GCC, GBS y servicios empresariales globales, Aokah combina IA con experiencia práctica codificada a partir de más de 300 programas empresariales de GCC e inteligencia
More news about: Aokah Inc
Apr 23, 2026, 04:00 ET Aokah Launches Explorer and Builder: The First AI-Powered Platform to Take Enterprises from GCC Strategy to Execution
built to orchestrate Global Capability Centers with foresight, speed, and resilience. Founded by a globally recognized team with over 25 years of GCC, GBS, and global business services leadership experience, Aokah combines agentic AI with practitioner expertise codified from 300+ enterprise GCC programs
More news about: Aokah Inc